CNS depression including slight [[Somnolence|drowsiness]] to deep sleep, lassitude, [[dizziness]], [[Ataxia|incoordination]]. [[Headache]], [[Psychomotor retardation|psychomotor impairment]] and [[Muscarinic antagonist|antimuscarinic]] effects. Rarely, [[rash]]es and [[Hypersensitivity|hypersensitivity reaction]]s, blood disorders, [[convulsion]]s, [[Perspiration|sweating]], [[myalgia]], [[Paresthesia|paraesthesias]], [[Extrapyramidal symptoms|extrapyramidal effect]]s, [[tremor]], [[confusion]], sleep and GI disturbances, [[tinnitus]], [[hypotension]], [[hair loss]]. [[Photosensitivity]], [[jaundice]].

 
Enhances effects of CNS depressants e.g. [[Ethanol|alcohol]], [[barbiturate]]s, [[hypnotic]]s, [[Opioid|opioid analgesic]]s, [[anxiolytic]]s and [[antipsychotic]]s. Can mask signs of [[ototoxicity]] caused by [[aminoglycoside]]s. [[QT interval|QT]] prolongation (which can lead to [[torsades de pointes]] arrhythmia) reported with [[spiramycin]].

 
* {{cite journal | last1 = Theunissen | first1 = EL | last2 = Vermeeren | first2 = A | last3 = van Oers | first3 = AC | last4 = van Maris | first4 = I | last5 = Ramaekers | first5 = JG | title = A Dose-Ranging Study of the Effects of Mequitazine on Actual Driving, Memory and Psychomotor Performance as Compared to Dexchlorpheniramine, Cetirizine and Placebo | journal = Clinical and Experimental Allergy | date = February 2004 | volume = 34 | issue = 2 | pages = 250â€“8 | doi = 10.1111/j.1365-2222.2004.01874.x | pmid = 14987305}}
